The article on GLP-1 for PCOS covers how semaglutide affects hormonal patterns in this population, and having baseline hormone levels makes those changes trackable
KEY TAKEAWAYS Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes, with demonstrated superior efficacy in glycemic control and weight loss compared to existing treatments
Clinicians should judiciously balance potential benefits against risks when considering the use of these agents in pregnant patients and, where feasible, engage in thorough preconception counseling.225,226 Future research should prioritize the evaluation of long-term safety outcomes during pregnancy and potential fetal effects to inform safer clinical practices
7,21,25 A phenomenon known as inflammaging, chronic low-level inflammation that often accompanies aging, is an important driver of atherosclerosis
Biological basis of the behavior of sick animals
This dual effect may make tirzepatide more effective than other injectable diabetes medications
